UBS’s EnteroMedics ETRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$10K Buy
8
+6
+300% +$8.79K ﹤0.01% 8898
2014
Q2
$3K Sell
2
-8
-80% -$15K ﹤0.01% 9981
2014
Q1
$19K Buy
+10
New +$23.7K ﹤0.01% 8213

Other funds holding ETRM

UBS's ETRM Position: Q3 2014 in Review

UBS reduced its EnteroMedics (ETRM) stake by 96% in Q3 2014, selling an estimated $68.9K and leaving 2 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #10121.

UBS first reported a position in ETRM in Q2 2013 and has held it in 4 quarters since. The position peaked at $80K in Q2 2014. 49 funds tracked by Wall St. Rank hold ETRM as of Q3 2014.

  • UBS held 2 shares of EnteroMedics worth $2K as of Q3 2014.
  • UBS sold 47 EnteroMedics shares in Q3 2014, an estimated $68.9K.
  • EnteroMedics made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10121 holding.
  • UBS first reported a position in EnteroMedics in Q2 2013 and has held it in 4 quarters since.
  • UBS's EnteroMedics position peaked at $80K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held EnteroMedics as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.